250 related articles for article (PubMed ID: 6681897)
1. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
Plotnick LP; Van Meter QL; Kowarski AA
Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
[TBL] [Abstract][Full Text] [Related]
2. Children with normal-variant short stature: treatment with human growth hormone for six months.
Rudman D; Kutner MH; Blackston RD; Cushman RA; Bain RP; Patterson JH
N Engl J Med; 1981 Jul; 305(3):123-31. PubMed ID: 7195462
[TBL] [Abstract][Full Text] [Related]
3. Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.
Bright GM; Rogol AD; Johanson AJ; Blizzard RM
Pediatrics; 1983 Apr; 71(4):576-80. PubMed ID: 6340044
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin response.
Wilson DM; Baker B; Hintz RL; Rosenfeld RG
Pediatrics; 1985 Sep; 76(3):361-4. PubMed ID: 4034296
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone treatment for short stature.
Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
[TBL] [Abstract][Full Text] [Related]
6. The short child with subnormal plasma somatomedin C.
Rudman D; Kutner MH; Chawla RK
Pediatr Res; 1985 Oct; 19(10):975-80. PubMed ID: 4058978
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between growth velocity and hematologic levels of somatomedin C during the treatment with growth hormones (GH) in subjects with "classic" and "non-classic" deficits of GH].
Saggese G; Cesaretti G; Cioni C; Bracaloni C; Giannessi N; Cinquanta L
Minerva Pediatr; 1993; 45(1-2):7-13. PubMed ID: 8316167
[TBL] [Abstract][Full Text] [Related]
8. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
[TBL] [Abstract][Full Text] [Related]
10. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
Huseman CA; Colombo JL; Brooks MA; Smay JR; Greger NG; Sammut PH; Bier DM
Pediatr Pulmonol; 1996 Aug; 22(2):90-5. PubMed ID: 8875581
[TBL] [Abstract][Full Text] [Related]
11. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
[TBL] [Abstract][Full Text] [Related]
12. [The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
Vicens-Calvet E; Seijo G; Potau N; de los Llanos Moreno M; Carrascosa A
Med Clin (Barc); 1999 May; 112(16):601-5. PubMed ID: 10374174
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency.
Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM
Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
[TBL] [Abstract][Full Text] [Related]
15. [Circulating somatomedin activity and growth hormone secretion. Changes during late diagnosed celiac disease and effects of treatment].
Bresson JL; Prévot C; Rappaport R; Czernichow P; Schmitz J; Rey J
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):XIII-XVIII. PubMed ID: 539880
[TBL] [Abstract][Full Text] [Related]
16. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
17. [Somatomedin activity and growth hormone secretion in children with idiopathic growth retardation (author's transl)].
Carrascosa A; Prevot C; Evain D; Czernichow P; Rappaport R
Arch Fr Pediatr; 1980 Oct; 37(8):515-9. PubMed ID: 7447606
[TBL] [Abstract][Full Text] [Related]
18. [Somatomedins].
Ranke MB; Blum W; Bierich JR
Wien Klin Wochenschr; 1987 May; 99(9):306-12. PubMed ID: 3604213
[TBL] [Abstract][Full Text] [Related]
19. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.
Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ
J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592
[No Abstract] [Full Text] [Related]
20. Changes in the levels of growth hormone, insulin, somatomedin C and thyroxine in sheep during immunization against somatostatin.
Spencer GS; Hallett KG; Fadlalla AM; Spencer EM
Endocrinol Exp; 1987 Dec; 21(4):299-306. PubMed ID: 2894294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
